Bridging the gap between pathologist and algorithm
Posted 16th October 2019 by Liv Sewell
Could AI replace pathologists? As we look forward to the 6th Digital Pathology and AI Congress: Europe on the 5th – 6th December 2019, we look back at Dr Hamid Tizhoosh’s keynote presentation from last year.
Poster Presentations Release: Microbiome Series Europe
Posted 14th October 2019 by Jane Williams
Presented at this year’s Microbiome Series: Europe, these poster presentations are now available to download and share with your colleagues.
Pixel analysis: the new era of digital pathology
Posted 9th October 2019 by Liv Sewell
Professor David Snead is leading the implementation of digital pathology for Coventry and Warwickshire Pathology Services and directs one of the five Government funded centres in the UK pioneering AI and image diagnostics integration. His main research interests lie in extending the capability of digital pathology for routine diagnostic use and the advancement and deployment of computer assisted diagnostic algorithms. In this third highlight from the conference we revisit Professor Snead’s presentation to get a clinical perspective on how deep learning and artificial intelligence (AI) are set to play an increasing role in daily practice.
New sourcing of natural ingredients for cosmeceuticals
Posted 7th October 2019 by Joshua Sewell
The sourcing of natural plant-based compounds is becoming a worldwide bottleneck. The Greenhouse Pharmacy programme of Wageningen University & Research builds new chains between high-tech horticulture and cosmeceutical companies for reliable sourcing of pesticide-free natural plant compounds.
Unleashing the power of digital pathology and AI for precision medicine
Posted 2nd October 2019 by Joshua Sewell
We’re looking back at the highlights from the Digital Pathology and AI meeting in 2018 as we anticipate this year’s Digital Pathology and AI Congress in December. This second post in our mini-series reviews Marylin Bui’s keynote presentation where she explained how the combination of Digital Pathology and Artificial Intelligence (AI) holds huge potential for patient care.
Will the intersection of blockchain and AI inspire the Pharma R&D Renaissance?
Posted 30th September 2019 by Joshua Sewell
Global Engage spoke to Scott Kahn ahead of the 3rdGlobal Pharma R&D Informatics and AI Congress. Scott is the CIO of Luna PBC, the entity that manages LunaDNA: a community-owned data-sharing resource. Their conversation was recorded as a podcast, which can be found here.
This is the second half of that conversation, where Scott discusses the challenges of distributive ledger technologies such as Blockchain, and their intersection with AI for Pharma R&D.
Digital Pathology and Deep Learning: AI assisting in PD-L1 scoring
Posted 25th September 2019 by Liv Sewell
Ahead of this year’s Digital Pathology and AI Congress in December we look back at some of the highlights from last year.
First up, Michel Vandenberghe’s presentation on a new deep learning algorithm, which demonstrates the potential of artificial Intelligence (AI) to support pathologists, has been developed for PD-L1 scoring in tumour cells and immune cells in urothelial carcinoma samples.
How to revolutionise clinical trials: engaging with participants as partners
Posted 23rd September 2019 by Joshua Sewell
Ahead of the 3rd Global Pharma R&D Informatics and AI Congress, Global Engage spoke to Scott Kahn, CIO of LunaPBC. LunaPBC is the company that manages LunaDNA: a community-owned data-sharing resource. Their conversation was recorded as a podcast, which can be found here.
In the first half of the conversation, Scott discusses the benefits of distributive ledger technologies such as Blockchain for Pharma R&D.
